drugset / Trial / NCT00995306

Evaluating the Safety and Efficacy Civamide in Osteoarthritis (OA) of the Knee(s)

NCT00995306 ↗

Phase 3 Completed 695 enrolled Winston Laboratories
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To evaluate the safety and efficacy of Civamide Cream 0.075% as a treatment of the signs and symptoms associated with osteoarthritis of the knee.

Timeline

Start
2003-06
Primary completion
2004-04
Completion
2004-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Zucapsaicin Small molecule 0.01 % Topical
Comparator Zucapsaicin Small molecule 0.075 % Topical

Indications